205 related articles for article (PubMed ID: 37341894)
1. Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis.
Ligia S; Musiu P; Serrao A; Santoro C; Taglietti A; Capriata M; Faccini A; Molinari MC; Baldacci E; Chistolini A
J Thromb Thrombolysis; 2023 Aug; 56(2):323-326. PubMed ID: 37341894
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature.
Schastlivtsev I; Lobastov K; Tsaplin S; Kanzafarova I; Barinov V; Laberko L; Rodoman G; Zhuravlev S
Thromb Res; 2019 Sep; 181():24-28. PubMed ID: 31326717
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).
Davies GA; Lazo-Langner A; Gandara E; Rodger M; Tagalakis V; Louzada M; Corpuz R; Kovacs MJ
Thromb Res; 2018 Feb; 162():88-92. PubMed ID: 28416213
[TBL] [Abstract][Full Text] [Related]
4. Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
Vedovati MC; Tratar G; Mavri A; Mazzetti M; Salazar Rosa V; Pierpaoli L; Cotugno M; Agnelli G; Becattini C
Int J Cardiol; 2021 Sep; 339():158-163. PubMed ID: 34245794
[TBL] [Abstract][Full Text] [Related]
5. Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience.
Porfidia A; Agostini F; Giarretta I; Tonello D; Pastori D; Pignatelli P; Santoliquido A; Sartori M; Lessiani G; Visonà A; Donadini MP; Pola R
J Thromb Thrombolysis; 2020 Aug; 50(2):355-360. PubMed ID: 32008208
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
[TBL] [Abstract][Full Text] [Related]
7. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
8. Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis Clinic.
Stone RH; Bress AP; Nutescu EA; Shapiro NL
Ann Pharmacother; 2016 Aug; 50(8):637-44. PubMed ID: 27189014
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis.
Levy MM; Albuquerque F; Pfeifer JD
Ann Vasc Surg; 2012 Oct; 26(7):964-72. PubMed ID: 22749742
[TBL] [Abstract][Full Text] [Related]
10. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry.
Galanaud JP; Trujillo-Santos J; Bikdeli B; Di Micco P; Bortoluzzi C; Bertoletti L; Pedrajas JM; Ballaz A; Alfonso J; Monreal M;
J Thromb Thrombolysis; 2021 Aug; 52(2):532-541. PubMed ID: 33247808
[TBL] [Abstract][Full Text] [Related]
11. Upper extremity deep venous thrombosis: reassessing the risk for subsequent pulmonary embolism.
Levy MM; Bach C; Fisher-Snowden R; Pfeifer JD
Ann Vasc Surg; 2011 May; 25(4):442-7. PubMed ID: 21549911
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
Bikdeli B; Zahedi Tajrishi F; Sadeghipour P; Talasaz AH; Fanikos J; Lippi G; Siegal DM; Eikelboom JW; Monreal M; Jimenez D; Connors JM; Ageno W; Barnes GD; Piazza G; Angiolillo DJ; Parikh SA; Kirtane AJ; Lopes RD; Bhatt DL; Weitz JI; Mehran R; Krumholz HM; Goldhaber SZ; Lip GYH
JAMA Cardiol; 2022 Jul; 7(7):747-759. PubMed ID: 35648414
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.
Bertoletti L; Gusto G; Khachatryan A; Quignot N; Chaves J; Moniot A; Mokgokong R
Thromb Haemost; 2022 Aug; 122(8):1384-1396. PubMed ID: 34983073
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study.
Xu J; Wang G; Chen X; Shen Y; Wang X; Wang H
Thromb J; 2023 Feb; 21(1):15. PubMed ID: 36726149
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006466. PubMed ID: 34622445
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020.
Mitrovic D; Emmens W; Naimi A; van der Mijle A; Veeger N; van Roon E; van den Bemt P
Clin Drug Investig; 2022 Jul; 42(7):593-598. PubMed ID: 35675030
[TBL] [Abstract][Full Text] [Related]
18. Benefice and pitfall of direct oral anticoagulants in very high-risk myeloproliferative neoplasms.
Herbreteau L; Papageorgiou L; Le Clech L; Garcia G; James C; Pan-Petesch B; Couturaud F; Gerotziafas G; Lippert E; Ianotto JC
Thromb Res; 2022 Aug; 216():25-34. PubMed ID: 35689962
[TBL] [Abstract][Full Text] [Related]
19. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
Finks SW; Trujillo TC; Dobesh PP
Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821
[TBL] [Abstract][Full Text] [Related]
20. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
